Nurix Therapeutics Inc. (NRIX)
14.16
-1.29 (-8.35%)
At close: Mar 03, 2025, 3:59 PM
14.47
2.15%
After-hours: Mar 03, 2025, 04:03 PM EST
Nurix Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 110M | 54.63M | 64.47M | 80.51M | 119.36M | 34.82M | 25.59M |
| Short-Term Investments | 499.59M | 233.28M | 244.67M | 215.21M | 161.79M | 2.9M | 13.45M |
| Long-Term Investments | n/a | 7.42M | 63.88M | 137.19M | 90.89M | 506K | 170K |
| Other Long-Term Assets | 4.06M | 4.72M | 4.92M | 3.12M | 347K | 317K | 151K |
| Receivables | n/a | n/a | n/a | 6.2M | 11.35M | n/a | n/a |
| Inventory | n/a | n/a | -1.1M | 1.00 | n/a | n/a | n/a |
| Other Current Assets | 9.8M | 7.59M | 9.31M | 9.4M | 5.94M | 1.63M | 1.61M |
| Total Current Assets | 619.39M | 295.5M | 318.45M | 311.12M | 298.43M | 39.35M | 40.65M |
| Property-Plant & Equipment | 45.9M | 47.95M | 29.51M | 25.34M | 6.67M | 3.87M | 4.42M |
| Goodwill & Intangibles | n/a | n/a | -3.3M | -3.33M | n/a | n/a | n/a |
| Total Long-Term Assets | 49.96M | 60.09M | 98.31M | 165.65M | 97.91M | 4.69M | 4.74M |
| Total Assets | 669.34M | 355.6M | 416.76M | 476.77M | 396.34M | 44.05M | 45.4M |
| Account Payables | 11.48M | 6.4M | 5.06M | 6.65M | 3.41M | 1.6M | 1.3M |
| Deferred Revenue | 38.36M | 48.1M | 37.63M | 41.21M | 32.8M | 9.61M | 28.42M |
| Short-Term Debt | 8.01M | 13.91M | 11.06M | 7.69M | n/a | n/a | n/a |
| Other Current Liabilities | 36.76M | 24.94M | 16.81M | 10.63M | 8.25M | 4.93M | 3.12M |
| Total Current Liabilities | 95.85M | 86.96M | 70.66M | 66.26M | 44.54M | 16.14M | 32.83M |
| Long-Term Debt | 20.29M | 23.13M | 6.43M | 9.19M | n/a | n/a | n/a |
| Other Long-Term Liabilities | 26.21M | n/a | n/a | n/a | 850K | 49.93M | 49.41M |
| Total Long-Term Liabilities | 46.5M | 68.15M | 42.41M | 68.21M | 61.53M | 85.63M | 49.41M |
| Total Liabilities | 142.35M | 155.1M | 113.06M | 134.47M | 106.07M | 101.76M | 82.24M |
| Total Debt | 28.3M | 30.61M | 11.96M | 13.04M | n/a | n/a | n/a |
| Common Stock | 76K | 49K | 47K | 45K | 39K | 4K | 3K |
| Retained Earnings | -738.77M | -545.2M | -401.25M | -220.89M | -103.7M | -60.46M | -38.76M |
| Comprehensive Income | 150K | -655K | -4.32M | -608K | 87K | -2K | -4K |
| Shareholders Equity | 526.99M | 200.49M | 303.7M | 342.3M | 290.27M | -57.71M | -36.85M |
| Total Investments | 499.59M | 240.7M | 308.55M | 352.4M | 252.68M | 3.41M | 13.45M |